Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review
出版年份 2021 全文链接
标题
Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review
作者
关键词
-
出版物
JOURNAL OF GENERAL INTERNAL MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-30
DOI
10.1007/s11606-020-06504-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evidence of a clinically significant drug‐drug interaction between cannabidiol and tacrolimus
- (2019) Abbie D. Leino et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research.
- (2019) Christina N. Nona et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration
- (2019) Laura E. Ewing et al. MOLECULES
- Important drug interactions exist between cannabidiol oil and commonly prescribed drugs in rheumatology practice
- (2019) Harold Wilson-Morkeh et al. RHEUMATOLOGY
- Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
- (2019) Joshua D. Brown et al. Journal of Clinical Medicine
- Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program
- (2019) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies
- (2019) Katarzyna Socała et al. NEUROPHARMACOLOGY
- The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin
- (2019) Yuli Qian et al. CHEMICO-BIOLOGICAL INTERACTIONS
- P.417 Effects of cannabidiol and sertraline on behavioral and neurochemical alterations induced by a new long-lasting animal model of PTSD
- (2019) A. Gasparyan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
- (2018) Amanda J. Sales et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabis for the Treatment of Epilepsy: an Update
- (2018) Tyler E. Gaston et al. Current Neurology and Neuroscience Reports
- Interaction between warfarin and cannabis
- (2018) Per Damkier et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
- (2018) Tine van de Donk et al. PAIN
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway
- (2017) Stephanie M. Todd et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
- (2017) Douglas L Boggs et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Is there a role for cannabidiol in psychiatry?
- (2017) Julia Machado Khoury et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cannabinoids and Cytochrome P450 Interactions
- (2016) Ondřej Zendulka et al. CURRENT DRUG METABOLISM
- Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action
- (2016) Maurício dos-Santos-Pereira et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
- (2016) Angélica Pupin Schiavon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice
- (2015) Harshini Neelakantan et al. BEHAVIOURAL PHARMACOLOGY
- Neural correlates of interactions between cannabidiol and Δ9-tetrahydrocannabinol in mice: implications for medical cannabis
- (2015) S M Todd et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
- (2015) Alex F. Manini et al. Journal of Addiction Medicine
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
- (2014) Lili Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Human cytochromes P450 in health and disease
- (2013) D. W. Nebert et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
- (2013) S. Sylantyev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines
- (2013) Valeria Feinshtein et al. PeerJ
- Pharmacokinetic Drug Interactions Between Clobazam and Drugs Metabolized by Cytochrome P450 Isoenzymes
- (2012) Mark Walzer et al. PHARMACOTHERAPY
- A case of a potential drug interaction between clobazam and etravirine-based antiretroviral therapy
- (2011) Mark Naccarato et al. ANTIVIRAL THERAPY
- Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
- (2011) S. Yamaori et al. DRUG METABOLISM AND DISPOSITION
- Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
- (2011) Rongrong Jiang et al. LIFE SCIENCES
- Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
- (2011) Satoshi Yamaori et al. LIFE SCIENCES
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
- (2008) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now